BIO-RAD LABORATORIES, INC. — Director's Dealing 2020

Sep 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO,BIOB)
CIK: 0000012208
Period of Report: 2020-09-02

Reporting Person: Daskal Ilan (EVP, Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-02	Restricted Stock Units	$0	A	2166	Acquired		Bio-Rad A Common Stock (2166)	Direct
2020-09-02	Non-Qualified Stock Option (right to buy)	$524.3	A	2166	Acquired	2030-09-02	Bio-Rad A Common Stock (2166)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Bio-Rad A Common Stock	457	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F2: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.

F3: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.